This article is the third in a three-part series about caring for a loved one with multiple myeloma. The first article provides an introduction to caring for a cancer patient as well as resources for caregivers. The second article provides practical tips for caregivers, and the third article explains the tolls of being a caregiver.

When Nan Manzo’s husband Dom was diagnosed with multiple myeloma in 2008, their family doctor shared some advice about how to deal with the ups …

This article is the second in a three-part series about caring for a loved one with multiple myeloma. The first article provides an introduction to caring for a cancer patient as well as resources for caregivers. The second article provides practical tips for caregivers, and the third article will explain the tolls of being a caregiver.

When Lori Puente’s husband Dave was diagnosed with multiple myeloma in 2008, she decided that she would need to take time off from work …

This article is the first in a three-part series about caring for a loved one with multiple myeloma. The first article provides an introduction to caring for a cancer patient as well as resources for caregivers. The second article will provide practical tips for caregivers, and the third article will explain the tolls of being a caregiver.

In October 2008, Dianna Allred’s husband, Mark, was diagnosed with multiple myeloma after suffering a severe spine fracture.

As Mark’s pain increased dramatically …

Eighth Canadian Province Approves Revlimid Funding – Revlimid (lenalidomide) in combination with dexamethasone (Decadron) is now funded and accessible in Manitoba, Canada for multiple myeloma patients who have been previously treated. Only two provinces, Nova Scotia and Prince Edward Island, deny access to myeloma patients who do not have private insurance. Myeloma Canada, an organization dedicated to supporting myeloma patients, will continue campaigning for universal coverage of Revlimid. For more information, please see the Myeloma Canada press release. …

NCI Begins Study Of Smoldering Myeloma And MGUS Patients – The National Cancer Institute (NCI) is recruiting patients for a study aimed at identifying causes of transformation from precursor conditions, smoldering myeloma and monoclonal gammopathy of undetermined significance (MGUS), to multiple myeloma. In addition, as previously reported at The Myeloma Beacon, the NCI is looking for relapsed or refractory myeloma patients for a Phase 2 study of AZD6244, a potential new treatment for multiple myeloma. This trial is still …